Slovenian researchers showed that genetic variability in GLP1R is associated with inter-individual differences in the weight-lowering-lowering potential of GLP-1 drugs in obese women with polycystic ovary syndrome (PCOS) in 2015, at a time when the main GLP-1 drug was liraglutide, which required daily injection
A, graphical representation of the DPP-4 enzyme with binding sites
The delicate balance of estrogen and testosterone that exists pre-menopause tends to keep body fat in the lower body, away from the belly, so the midlife estrogen dip can leave women perplexed and upset when their pants no longer buttoneven if theyre still eating well and exercising
doi: 10.3389/fphar.2026.1754721 Received 26 November 2025 Revised 28 February 2026 Accepted 03 March 2026 Published 19 March 2026 Volume 17 - 2026 Edited by Achuthan Raghavamenon, Amala Cancer Research Centre, India Reviewed by Abdul Rahim Chethikkattuveli Salih, Terasaki Institute for Biomedical Innovation, United States Julio Plaza-Diaz, Childrens Hospital of Eastern Ontario (CHEO), Canada Updates Copyright 2026 Hu, Tian, Yang, Zhang, Zhang, Xu and Lu
Pending the results of the Focus Trial, advocacy for early prophylactic intervention remains a minority opinion, with most opting to continue standard thresholds for treatment
